|
시장보고서
Advances in Signal Transduction based Drug Discovery
|
Abstract
This research service outlines the key global developments in the field of
signal transduction.
Table of Contents
1 EXECUTIVE SUMMARY
- Scope and Methodology
- Scope and Segmentation of the Research Service
- Research Methodology
- Role of Signal Transduction in Drug Discovery
- Drug Discovery--The Changing Paradigm
- Industry Scenario in Signal Transduction
- Signal Transduction-Based Drug Discovery--Technology
2 TECHNICAL DEVELOPMENTS
- Technology Primer
- Major Families of Signal Transducing Molecules
- Rationale of Pathway Maps in Drug Discovery
- Cell-Based Assay Approach to Drug Discovery
- Assessment of Enabling Technologies - Informatics or Cell-Based Approach
- An Informatics-Based Discovery Engine for GPCRs--Israel
- Distinct Activated Checkpoint Therapy Platform For Drug Discovery--USA
- Biological Illustration and Biopathway Modeling Software Tool--Japan
- SureFire Technology Assists in Cell-Based Screening--USA
- Functional Protein Arrays Assist in Detecting Kinases--UK
- Nanoprobes Can Identify Cells in Action--USA
- Platform to Assist in Protein Kinase Analysis--USA
- Biosensor Dye to Study Signaling in Live Cells--USA
- Pathway Analysis Tool to Assist in Drug Discovery--India
- Cell-Based Screening Assisted with a Flexible Tag--USA
- Proteomics Platform to Discover Protein Phosphorylation--USA
- Signal Transduction Protein Array--First of its Kind--USA
- A High-Throughput Ion Channel Screening Service--UK
- Cell-Based Technology Hastens Drug Discovery Process--USA
- A GPCR Internalization Assay--Denmark
3 TECHNOLOGY ADOPTION FACTOR ANALYSIS
- Competitive Landscape
- Industry Insights
- Analysis of the Druggable Genome And Explorable Targets
- Stakeholder Analysis
- Geographic Trend Analysis
4 PATENTS AND DATABASE OF KEY INDUSTRY PARTICIPANTS
- Patents
- Kinase Patents
- G-protein Coupled Receptor Patents
- Ion-channel Receptor Patents
- Patent Analysis
- Key Industry Participants; Glossary
- Key Participants
- Glossary of Signaling Molecules
5 DECISION SUPPORT DATABASE
- Database Tables
- Global R&D Expenditure for Biotechnology (2002-2012)
- Percent Government R&D Investment in Biotechnology (2002-2012)
- Global Pharmaceutical R&D Expenditure (2002-2012)
- Global Percentage Pharmaceutical R&D Expenditure (2002-2012)
|
